Alliance brings together complementary strengths in commercialization strategy, cross-functional launch readiness, ...
SHANGHAI and GAITHERSBERG, Md., July 28, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and ...
While the Trump administration remains unpredictable, some pharma experts are optimistic that the regulatory landscape will ...
The pharmaceutical commercialization landscape is becoming increasingly complex. Tried and true paradigms for capturing market share and securing reimbursement must evolve in the face of demand for ...
True patient-centricity will drive commercial success as CGT moves beyond first-generation therapies. Current timelines in CGT, from diagnosis to treatment, can exceed six months, often compounded by ...
VANCOUVER, BC / ACCESSWIRE / November 20, 2023 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to provide further details on its clinical and ...
The Chosun Ilbo on MSN
Motional prioritizes safety, LDM for autonomous commercialization
On the 8th, local time, a briefing held at the U.S. Las Vegas Technical Center of Motional, the U.S. subsidiary of Hyundai ...
Arrowhead Pharmaceuticals is transitioning from a pre-commercialization phase to a fully commercial pharmaceutical company. The company is focused on bringing candidate drugs in varied disease ...
The Chosun Ilbo on MSN
Motional unveils 2026 unmanned robotaxi commercialization plan
Hyundai Motor Group’s autonomous driving subsidiary ‘Motional’ publicly disclosed its technical site to the media for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback